Status:
COMPLETED
Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
Lead Sponsor:
Abbott
Conditions:
Kidney Failure, Chronic
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
To show non-inferiority in the incidence rates of elevated calcium-phosphorus product between two treatment groups: 1) a group having an initial dose based on baseline PTH (baseline iPTH/80) and 2) a ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Stage V Chronic Kidney Disease
- Patients on Hemodialysis requiring treatment for secondary hyperparathyroidism with vitamin D therapy
Exclusion
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT00091481
Start Date
June 1 2003
Last Update
September 26 2007
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Errikos Dynan Hospital
Ambelokipi, Athens, Greece, 11526
2
General Hospital of Athens, "G.Gennimatas"
Cholargós, Athens, Greece, 11527
3
General Hospital of Attica "Sismanoglio"
Marousi, Athens, Greece, 15126
4
"Hygeia" Diagnosis and Therapy Center
Marousi, Athens, Greece, 152 00